12. December 2011 15:49
The Indian Pharmaceutical Summit 2011 was meant to prepare a road map on the challenges and opportunities facing the country as it gears to assume global leadership in generic medicine manufacture.
The India Pharmaceutical Summit 2011 was held in New Delhi on 29 November. Its objective: to prepare a road map on the opportunities and challenges facing the country as it seeks to assume global leadership in generic medicine manufacture. Regulatory issues and the fostering of global industry-institutional-academic linkages in a partnership mode were integral to the vision for the summit as articulated by the Press Information Bureau of the Government of India’s Ministry of Chemicals and Fertilisers. Participants at the summit included senior government officials, representatives of the pharmaceutical industry, and members of academia.
In his inaugural address, Mr. Srikant Kumar Jena, Minister of State for Chemicals and Fertilizers, spoke of the country’s potential to play a leading role in the field of generic medicines. He stressed the need for research and development and said the summit would help stakeholders come together to evolve new ideas and plans. Mr. Jena spoke also of the government’s commitment to providing quality medicines at affordable prices. In pursuance of that objective, the government had initiated the Jan Aushadi scheme for providing generic medicines to the maximum number of people, the minister said.